Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rede Académica das Ciências da Saúde da Lusofonia - RACS
2022-04-01
|
| Series: | RevSALUS |
| Subjects: | |
| Online Access: | https://revsalus.com/index.php/RevSALUS/article/view/401 |
| _version_ | 1811219677429366784 |
|---|---|
| author | Filipa Amaro Carolina Pisoeiro Maria João Valente Vera Miranda-Gonçalves Carmen Jerónimo Rui Henrique Maria de Lourdes Bastos Paula Guedes de Pinho Márcia Carvalho Joana Pinto |
| author_facet | Filipa Amaro Carolina Pisoeiro Maria João Valente Vera Miranda-Gonçalves Carmen Jerónimo Rui Henrique Maria de Lourdes Bastos Paula Guedes de Pinho Márcia Carvalho Joana Pinto |
| author_sort | Filipa Amaro |
| collection | DOAJ |
| first_indexed | 2024-04-12T07:29:56Z |
| format | Article |
| id | doaj.art-19c2a52f387340669fd2d76379b31511 |
| institution | Directory Open Access Journal |
| issn | 2184-4860 2184-836X |
| language | English |
| last_indexed | 2024-04-12T07:29:56Z |
| publishDate | 2022-04-01 |
| publisher | Rede Académica das Ciências da Saúde da Lusofonia - RACS |
| record_format | Article |
| series | RevSALUS |
| spelling | doaj.art-19c2a52f387340669fd2d76379b315112022-12-22T03:42:05ZengRede Académica das Ciências da Saúde da Lusofonia - RACSRevSALUS2184-48602184-836X2022-04-014Sup10.51126/revsalus.v4iSup.401Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinomaFilipa Amaro0Carolina Pisoeiro1Maria João Valente2Vera Miranda-Gonçalves3Carmen Jerónimo4Rui Henrique5Maria de Lourdes Bastos6Paula Guedes de Pinho7Márcia Carvalho8Joana Pinto9Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.National Food Institute, Technical University of Denmark, Kongens Lyngby, Copenhagen, Denmark Cancer Biology & Epigenetics Group–Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal.Cancer Biology & Epigenetics Group–Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal. Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal.Cancer Biology & Epigenetics Group–Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal. Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal. Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar–University of Porto, Porto, Portugal.Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. FP-I3ID, FP-BHS, University Fernando Pessoa, Porto, Portugal. Faculty of Health Sciences, Fernando Pessoa University, Porto, Portugal.Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal.https://revsalus.com/index.php/RevSALUS/article/view/401renal cell carcinomatyrosine kinase inhibitorsantiproliferativecytotoxicityin vitro |
| spellingShingle | Filipa Amaro Carolina Pisoeiro Maria João Valente Vera Miranda-Gonçalves Carmen Jerónimo Rui Henrique Maria de Lourdes Bastos Paula Guedes de Pinho Márcia Carvalho Joana Pinto Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma RevSALUS renal cell carcinoma tyrosine kinase inhibitors antiproliferative cytotoxicity in vitro |
| title | Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma |
| title_full | Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma |
| title_fullStr | Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma |
| title_full_unstemmed | Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma |
| title_short | Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma |
| title_sort | differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma |
| topic | renal cell carcinoma tyrosine kinase inhibitors antiproliferative cytotoxicity in vitro |
| url | https://revsalus.com/index.php/RevSALUS/article/view/401 |
| work_keys_str_mv | AT filipaamaro differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma AT carolinapisoeiro differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma AT mariajoaovalente differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma AT veramirandagoncalves differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma AT carmenjeronimo differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma AT ruihenrique differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma AT mariadelourdesbastos differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma AT paulaguedesdepinho differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma AT marciacarvalho differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma AT joanapinto differentialcellulareffectsofsunitinibandpazopanibtargeteddrugsformetastaticrenalcellcarcinoma |